medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Number 3

<< Back Next >>

Rev Invest Clin 2019; 71 (3)

Real-World Evidence of Dengue Burden on Hospitals in Mexico: Insights From the Automated Subsystem of Hospital Discharges (Saeh) Database

Macías AE, Puentes-Rosas E, Velandia D, Morley D, Coudeville L, Baurin N

Language: English
References: 39
Page: 168-177
PDF size: 411.57 Kb.


ABSTRACT

Background: The incidence of dengue in Mexico has increased in recent decades. It has been suggested that dengue outbreaks may compromise treatment quality in hospitals. Objective: The objective of the study was to quantify the burden imposed by dengue on hospital services in Mexico. Methods: We analyzed 19.2 million records contained in the database of hospital services of the Mexican Ministry of Health between 2008 and 2014. The number of admissions due to dengue was compared to other potentially preventable hospitalizations. Hospital departments were categorized to reflect denguerelated activity as high dengue activity (HDA), low dengue activity (LDA), or zero dengue activity departments, and the impact of dengue activity on general in-hospital mortality in HDA departments was assessed. Results: Dengue was the cause of more hospital admissions than most of the potentially preventable prevalent acute and chronic conditions and other infectious diseases. In HDA departments, dengue patient load was found to be a significant risk factor for overall in-hospital mortality. There was an approximately two-fold higher dengue case-fatality rate in LDA versus HDA departments, irrespective of dengue severity. Conclusions: This study confirms that dengue is an important cause of hospitalization in Mexico and highlights the impact of dengue activity not only on dengue case-fatality rate but also on the overall in-hospital mortality.


REFERENCES

  1. Ebi KL, Nealon J. Dengue in a changing climate. Environ Res. 2016;151:115-23.

  2. WHO. World Health Organization, Dengue and Severe Dengue- Fact Sheet; 2017. Available from: http://www.who.int/mediacentre/ factsheets/fs117/en/. [Last Accessed 2017 Dec 1] .

  3. Nogueira RM, Miagostovich MP, Schatzmayr HG, et al. Dengue in the state of Rio De Janeiro, Brazil, 1986-1998. Mem Inst Oswaldo Cruz. 1999;94:297-304.

  4. Pan American Health Organization (PAHO)/World Health Organization. PLISA Health Platform for the Americas. Topics, Dengue, Regional. Available from: http://www.paho.org/data/ indexphp/en/mnu-topics/indicadores-dengue-en/dengue-regional- en.html. [Last accessed on 2018 Jun 13].

  5. Sarti E, L’Azou M, Mercado M, et al. A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America. Int J Infect Dis. 2016;44:44-9.

  6. Pavía-Ruz N, Rojas DP, Villanueva S, et al. Seroprevalence of dengue antibodies in three urban settings in Yucatan, Mexico. Am J Trop Med Hyg. 2018;98:1202-8.

  7. Amaya-Larios IY, Martínez-Vega RA, Mayer SV, et al. Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of morelos, Mexico. Am J Trop Med Hyg. 2014;91:1057-65.

  8. Hernández-Gaytán SI, Díaz-Vásquez FJ, Duran-Arenas LG, López Cervantes M, Rothenberg SJ. 20 years spatial-temporal analysis of dengue fever and hemorrhagic fever in Mexico. Arch Med Res. 2017;48:653-62.

  9. Undurraga EA, Betancourt-Cravioto M, Ramos-Castañeda J, et al. Economic and disease burden of dengue in Mexico. PLoS Negl Trop Dis. 2015;9:e0003547.

  10. Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014;2:3.

  11. Dantés OG, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. Sistema de salud de México. Salud Pública Méx. 2011; 53:S220-32.

  12. Australian Government, Australian Institute of Health and Welfare. Metadata Online Registry. National Healthcare Agreement: PI 18-Selected Potentially Preventable Hospitalisations; 2015. Available from: [Last accessed 2017 Dec 2].

  13. International Statistical Classification of Diseases and Related Health Problems, 10th Revision; 2010. Available from: http:// www.apps.who.int/classifications/icd10/browse/2010/en#/.

  14. ENSANUT. Encuesta Nacional de Salud y Nutrición, Resultados Nacionales 2012. Síntesis Ejecutiva; 2012. Available from: http://www.ensanut.insp.mx/doctos/ENSANUT2012_Sint_ Ejec-24oct.pdf.

  15. Australian Institute of Health and Welfare. National Healthcare Agreement: PI 18-Selected Potentially Preventable Hospitalisations. Canberra: Australian Institute of Health and Welfare; 2017.

  16. MySQL. MySQL Workbench 6.3.6. Available from: https://www. mysql.com/.

  17. KNIME. KNIME 3.4.2. Available from: https://www.knime.com/.

  18. The R Foundation. R: a language and Environment for Statistical Computing. Foundation for Statistical Computing. Vienna, Austria; 2013. Available from: http://www.R-project.org/.

  19. San Martín JL, Brathwaite O, Zambrano B, et al. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg. 2010;82:128-35.

  20. Hurtado-Díaz M, Riojas-Rodríguez H, Rothenberg SJ, Gomez- Dantés H, Cifuentes E. Short communication: impact of climate variability on the incidence of dengue in Mexico. Trop Med Int Health. 2007;12:1327-37.

  21. Richardson V, Sánchez-Uribe E, Esparza-Aguilar M, Esteves-Jaramillo A, Suárez-Idueta L. Contribution of Mexico’s universal immunization program to the fourth millennium development goal. Rev Panam Salud Publica. 2014;35:248-55.

  22. Zubieta-Zavala A, Salinas-Escudero G, Ramírez-Chávez A, et al. Calculation of the average cost per case of dengue fever in Mexico using a micro-costing approach. PLoS Negl Trop Dis. 2016;10:e0004897.

  23. Ladner J, Rodrigues M, Davis B, et al. Societal impact of dengue outbreaks: stakeholder perceptions and related implications. A qualitative study in Brazil, 2015. PLoS Negl Trop Dis. 2017; 11:e0005366.

  24. Drennan K, Hicks P, Hart G. Impact of pandemic (H1N1) 2009 on Australasian critical care units. Crit Care Resusc. 2010; 12:223-9.

  25. Leuenberger D, Hebelamou J, Strahm S, et al. Impact of the ebola epidemic on general and HIV care in macenta, forest guinea, 2014. AIDS. 2015;29:1883-7.

  26. Baurin N, Morley D, Ochiai L, Guergova-Kuras M, Afshar M, Coudeville L. Management of Dengue Hospitalizations in Brazil During and Outside Epidemic Periods: insights from Data Mining. ASTMH 2016 Abstract 212; 2016. Available from: https:// www.astmh.org/ASTMH/media/Documents/ASTMH- 2016-Annual-Meeting-Abstract-Book.pdf. [Last accessed 2017 Dec 2].

  27. Pan American Health Organization/World Health Organization. Dengue: annual Cases Reported of Dengue; 2017. Available from: http://www.paho.org/hq/indexphp?option=com_topics& view=rdmore&cid=6290&Itemid=40734. [Last accessed 2018 Mar 22].

  28. Gaxiola-Robles R, Celis A, Serrano-Pinto V, Orozco-Valerio Mde J, Zenteno-Savín T. Mortality trend by dengue in Mexico 1980 to 2009. Rev Invest Clin. 2012;64:444-51.

  29. Rowe EK, Leo YS, Wong JG, et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected]. PLoS Negl Trop Dis. 2014;8:e2777.

  30. Gonzalez-Gonzalez C, Tysinger B, Goldman DP, Wong R. Projecting diabetes prevalence among Mexicans aged 50 years and older: the future elderly model-mexico (FEM-Mexico). BMJ Open. 2017;7:e017330.

  31. Lum LC, Syed Omar SF, Sri La Sri Ponnampalavanar S, et al. Cohorting dengue patients improves the quality of care and clinical outcome. PLoS Negl Trop Dis. 2015;9:e0003836.

  32. Halstead SB, Lum LC. Assessing the prognosis of dengue-infected patients. F1000 Med Rep. 2009;1:73.

  33. de Silva PK, Jayawardena P, Jayarajah U, et al. Improving clinical outcomes through setting up of a specialised dengue treatment unit. Int J Adv Res (Indore). 2017;5:1152-3.

  34. Sridhar S, Luedtke A, Langevin E, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018; 379:327-40.

  35. World Health Organization. Dengue Vaccine: WHO Position Paper; 2018. Available from: http://www.apps.who.int/iris/ bitstream/handle/10665/274315/WER9336.pdf?ua=1. [Last accessed on 2018 Sep 17].

  36. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011;84:200-7.

  37. Muller DA, Depelsenaire AC, Young PR. Clinical and laboratory diagnosis of dengue virus infection. J Infect Dis. 2017; 215:S89-95.

  38. Dantés HG, Farfán-Ale JA, Sarti E. Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. PLoS Negl Trop Dis. 2014;8:e3158.

  39. Palmu AA, Kilpi TM, Rinta-Kokko H, et al. Pneumococcal conjugate vaccine and clinically suspected invasive pneumococcal disease. Pediatrics. 2015;136:e22-7




2020     |     www.medigraphic.com